Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration

Z. Rákosy, Szilvia Ecsedi, R. Tóth, Laura Vizkeleti, Hector Herandez-Vargas, Viktoria Lazar, Gabriella Emri, I. Szatmári, Zdenko Herceg, R. Ádány, M. Balázs

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.

Original languageEnglish
Article numbere54958
JournalPLoS One
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 30 2013

Fingerprint

melanoma
Genomics
Melanoma
Genes
genomics
Methylation
methylation
Down-Regulation
genes
Gene expression
gene expression
Transcriptome
Overlapping Genes
Cell-Matrix Junctions
Genome
Gene Expression
promoter regions
Gene Dosage
beta Catenin
Gene Silencing

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration. / Rákosy, Z.; Ecsedi, Szilvia; Tóth, R.; Vizkeleti, Laura; Herandez-Vargas, Hector; Lazar, Viktoria; Emri, Gabriella; Szatmári, I.; Herceg, Zdenko; Ádány, R.; Balázs, M.

In: PLoS One, Vol. 8, No. 1, e54958, 30.01.2013.

Research output: Contribution to journalArticle

Rákosy, Z. ; Ecsedi, Szilvia ; Tóth, R. ; Vizkeleti, Laura ; Herandez-Vargas, Hector ; Lazar, Viktoria ; Emri, Gabriella ; Szatmári, I. ; Herceg, Zdenko ; Ádány, R. ; Balázs, M. / Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration. In: PLoS One. 2013 ; Vol. 8, No. 1.
@article{19dd1733a7c14b508eb7c229dce5f8e8,
title = "Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration",
abstract = "Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.",
author = "Z. R{\'a}kosy and Szilvia Ecsedi and R. T{\'o}th and Laura Vizkeleti and Hector Herandez-Vargas and Viktoria Lazar and Gabriella Emri and I. Szatm{\'a}ri and Zdenko Herceg and R. {\'A}d{\'a}ny and M. Bal{\'a}zs",
year = "2013",
month = "1",
day = "30",
doi = "10.1371/journal.pone.0054958",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration

AU - Rákosy, Z.

AU - Ecsedi, Szilvia

AU - Tóth, R.

AU - Vizkeleti, Laura

AU - Herandez-Vargas, Hector

AU - Lazar, Viktoria

AU - Emri, Gabriella

AU - Szatmári, I.

AU - Herceg, Zdenko

AU - Ádány, R.

AU - Balázs, M.

PY - 2013/1/30

Y1 - 2013/1/30

N2 - Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.

AB - Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.

UR - http://www.scopus.com/inward/record.url?scp=84873881608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873881608&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0054958

DO - 10.1371/journal.pone.0054958

M3 - Article

C2 - 23383013

AN - SCOPUS:84873881608

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e54958

ER -